<DOC>
	<DOCNO>NCT02798146</DOCNO>
	<brief_summary>This pilot-study help characterize serum progesterone profile IVF patient correlate progesterone level ovarian follicle obtain stimulation exogenous gonadotropin .</brief_summary>
	<brief_title>Early Luteal Progesterone Profile After hCG Triggering</brief_title>
	<detailed_description>The early luteal progesterone profile IVF differ significantly progesterone profile natural cycle , peak reach around time implantation . With non-invasive trial investigator wish explore early luteal phase profile progesterone hCG order optimize current luteal phase support policy IVF hopefully increase ongoing pregnancy rate . Stimulation , monitoring , oocyte pick-up perform accord standard procedure clinic . On day trigger 5.000 IU hCG blood sample drawn prior trigger subsequent analysis . Moreover , ovarian follicle side equal 11 mm register . Oocyte pick-up timing trigger bolus perform accord standard procedure unit . A total 10 blood sample draw trial - please see `` blood sampling '' . Blood sample collect follow day subsequent analysis LH , E2 , hCG progesterone . All embryos cryo-preserved transfer subsequent frozen/thaw embryo transfer cycle . Primary endpoint Serum concentration progesterone , LH , E2 , hCG early luteal phase . Secondary endpoint The correlation follicles ≥ 11 mm progesterone early luteal phase Data analyze use SPSS version 20 software . All test two tail , P &lt; 0.05 consider statistically significant . Continuous variable present mean +/- SD test student 's t-test . Categorical data express number compare use Chi-square test .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>IVF patient meet follow criterion : Freeze cycle hCG trigger Age 18 38 Body Mass Index ( BMI ) &lt; 28kg/m2 Normal ovarian reserve , define AntiMullerian Hormone ( AMH ) &gt; 1.25 ng/ml Antral Follicle Count ( AFC ) ≥ 6 measure within two month prior stimulation start Receiving Gonadotropin Releasing Hormone Antagonist cotreatment ovarian stimulation Agreement participate study , disclose medical event investigator . The subject must willing able comply protocol requirement duration study . Have give write informed consent understand subject may withdraw consent time without prejudice future medical care . Previous poor response ( ≤ 3 oocyte ) high dose FSH stimulation Hyperresponse define &gt; 20 follicle ≥ 14 mm Chronical medical condition like Diabetes , Crohns disease , Thyroid disease , Hepatitis B Sexually Transmitted Diseases Simultaneous participation interventional clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>in-vitro fertilization</keyword>
	<keyword>luteal phase</keyword>
</DOC>